INTS vs UDR · $7.7M cap vs P/E 26, rev $1.67B
Intensity Therapeutics, Inc. Common stock (INTS) versus UDR Inc (UDR) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
UDR Inc (UDR) is a reit - residential company listed on NYSE.
INTS does not have a complete income-statement cache yet.
Latest reported UDR revenue for 2024-12-31 was $1.67B. Net income was $95.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
INTS currently screens at market cap $7.7M. UDR currently screens at market cap $13.95B and trailing P/E 25.6.
Not investment advice. Open the INTS and UDR stock pages for the full models.
Not investment advice.